The invention
Stapokibart: redefining the boundaries of nasal disorder treatment
M: Medicine – Surgery – Orthopaedics – Material for disabled
Informations
- Stand number
- C21
- Exhibition class
- M: Medicine – Surgery – Orthopaedics – Material for disabled
- Technical description
- Stapokibart, a humanized IL4Rα mAb, inhibits type 2 inflammation. It is a treatment for seasonal allergic rhinitis (SAR) and also addresses chronic rhinosinusitis with nasal polyps (CRSwNP).
- Simplified description
- Stapokibart is a groundbreaking treatment that helps reduce type 2 inflammation. It's a medication for easing seasonal allergies and also helps with chronic sinus issues with nasal polyps.
Inventors
Keymed Biosciences (Chengdu) Co.,Ltd
inventor 3701634005_4272
Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.